Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 8:33 PM UTC
| NCT Number | NCT06468228 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | Clinical Trial |
| Target Enrollment | 1,280 participants |
| Active Locations | 63 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | May 28, 2026 (4 days ago) |
As of June 1, 2026: Clinical trial NCT06468228 is currently active_not_recruiting participants. This clinical trial study for hidradenitis suppurativa is not currently accepting new participants at 63 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06468228 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06468228 was last updated 4 days ago (May 28, 2026). HelloStudys verifies this status automatically.